-
DOCTORAL RESEARCHER in Bioinformatics/Computational Biology and Toxicology The position is a fixed term position until 31 December 2026. The start date is flexible, as soon as the recruitment decision is
-
European Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the Nordic EMBL Partnership aims to foster
-
European Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the Nordic EMBL Partnership aims to foster
-
and biotic stresses. We utilize state-of-the-art LC-MS and RNA-seq techniques to address significant questions in tRNA biology, for example how post-transcriptional tRNA modification dynamics influences
-
Application Deadline 9 May 2024 - 23:00 (Europe/Helsinki) Type of Contract Temporary Job Status Full-time Offer Starting Date 1 Jun 2024 Is the job funded through the EU Research Framework Programme? Not funded
-
European Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the Nordic EMBL Partnership aims to foster
-
researcher (PhD student), who recently completed their MSc degree in the field of Physics, Chemistry, Computational Biology or any other similar area with good experience in Linux/Unix operating system usage
-
-throughput omics, molecular biology, drug library screens, characterization of the patient cohorts and the functional studies in experimental models. This is a new and exciting research field, with the goals
-
approaches can identify new targets for colon cancer (Vande Voorde, Nature Metabolism, 2023). The oncogenic status of cancer cells alters the metabolic program of cancer cells and cancer metastasis (Najumudeen
-
to join our team. The candidate should hold a PhD degree in computer/data science, computational biology, or related fields. Experience in working with biological applications are considered highly